We are live on
!
Find out more
MYOK
MyoKardia, Inc. Common Stock
MYOK
MYOK
Delisted
MYOK was delisted on the 16th of November, 2020.
0 hedge funds and large institutions have $0 invested in MyoKardia, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 236 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% less funds holding
Funds holding: 237 → 0 (-237)
100% less funds holding in top 10
Funds holding in top 10: 18 → 0 (-18)
100% less capital invested
Capital invested by funds: $7.67B → $0 (-$7.67B)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 236
Holders
–
Holders Change
-237
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-18
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
236
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.08B |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$747M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$602M |
| 4 |
BlackRock
New York
|
-$578M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
-$410M |